Published in Gene Therapy Weekly, March 22nd, 2007
"MISSION siRNA Druggable Genome Libraries offer the most compelling siRNA collections available today by targeting genes of high therapeutic value as defined with input from major pharmaceutical companies," said Dr. David Smoller, Vice President of R&D at Sigma-Aldrich. "The flexible format of MISSION siRNA libraries facilitate research for life scientists...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.